These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11365893)

  • 21. The HYDILE trial: efficacy and tolerance of a quadruple combination of reverse transcriptase inhibitors versus the same regimen plus hydroxyurea or hydroxyurea and interleukin-2 in HIV-infected patients failing protease inhibitor-based combinations.
    Lafeuillade A; Hittinger G; Chadapaud S; Maillefet S; Rieu A; Poggi C
    HIV Clin Trials; 2002; 3(4):263-71. PubMed ID: 12187499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A patient with no options?
    Feinberg J; Henry K
    AIDS Clin Care; 1998 Aug; 10(8):61, 63-4. PubMed ID: 11365684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What's new and what's next.
    Fakuda D
    Posit Dir News; 1998 Jan; 10(1):25-9. PubMed ID: 11365053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Standard treatments for HIV, Spring 1997.
    Smith D
    AIDS Treat News; 1997 Apr; (No 269):4-5. PubMed ID: 11364255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative biological and clinical outcomes after a switch from a virologically unsuccessful first protease inhibitor-containing antiretroviral combination to a 3-drug regimen containing efavirenz, nevirapine, or abacavir.
    Abgrall S; Yeni PG; Bouchaud O; Costagliola D;
    Clin Infect Dis; 2007 Jan; 44(1):120-7. PubMed ID: 17143827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A review of dual protease inhibitor therapy.
    Gallant JE
    Hopkins HIV Rep; 1998 May; 10(3):1, 4-5. PubMed ID: 11365490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Looking past two drugs, looking past three?
    Mascolini M
    J Int Assoc Physicians AIDS Care; 1997 Feb; 3(2):9-15, 18-22, 46. PubMed ID: 11364100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dustup darkens HIV's mean streets or, can an old immune system sweep clean?
    Mascolini M
    J Int Assoc Physicians AIDS Care; 1998 Mar; 4(3):12-23, 27-36. PubMed ID: 11365177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIV resistance: the new enemy.
    Colvin R
    Common Factor; 1997 Nov; (No 11):6-7. PubMed ID: 11364845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. '96-'97 new drugs and the nominees for 1997 are...
    Notes Undergr; 1997; (No 35):suppl 1-2. PubMed ID: 11364566
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of the naive patient.
    Bartlett JG
    Hopkins HIV Rep; 1999 Mar; 11(2):1, 10-1. PubMed ID: 11366244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patient HIV-1 strains carrying the multiple nucleoside resistance mutations are cross-resistant to abacavir.
    Van Laethem K; Witvrouw M; Balzarini J; Schmit JC; Sprecher S; Hermans P; Leal M; Harrer T; Ruiz L; Clotet B; Van Ranst M; Desmyter J; De Clercq E; Vandamme AM
    AIDS; 2000 Mar; 14(4):469-71. PubMed ID: 10770556
    [No Abstract]   [Full Text] [Related]  

  • 33. [Enduringly effective and tolerable initial therapy of HIV. Even after 5 years no resistance].
    MMW Fortschr Med; 2003 Dec; 145(50):60-1. PubMed ID: 14963980
    [No Abstract]   [Full Text] [Related]  

  • 34. Genotypic and phenotypic nevirapine resistance correlates with virological failure during salvage therapy including abacavir and nevirapine.
    Jørgensen LB; Katzenstein TL; Gerstoft J; Mathiesen LR; Pedersen C; Nielsen C
    Antivir Ther; 2000 Sep; 5(3):187-94. PubMed ID: 11075938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiviral update.
    PI Perspect; 1997 Mar; (No 21):8-10. PubMed ID: 11364216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Don't mix Sustiva with Fortovase.
    Posit Aware; 1998; 9(5):17. PubMed ID: 11365885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fifth Conference on Retroviruses & Opportunistic Infections. Interview by Ron Baker.
    Follansbee S; Deeks S; Bartnoff H
    Newsline People AIDS Coalit N Y; 1998 Mar; ():7-14. PubMed ID: 11367453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The new age of HIV/AIDS. A special report on the XI International Conference on AIDS].
    Detres LL
    Sidahora; 1996; ():26-33. PubMed ID: 11364380
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Summary of the 5th Conference on Retroviruses and Opportunistic Infections.
    Bartlett JG
    Hopkins HIV Rep; 1998 Mar; 10(2):1-10, 12. PubMed ID: 11365136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term analysis of the resistance development in HIV-1 positive patients treated with protease and reverse transcriptase inhibitors: correlation of the genotype and disease progression.
    Václavíková J; Weber J; Machala L; Reinis M; Linka M; Brůcková M; Vandasová J; Stanková M; Konvalinka J
    Acta Virol; 2005; 49(1):29-36. PubMed ID: 15929396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.